SCHEMBL19011964

SCHEMBL19011964

CCCCC(CCC)c1coc(C)n1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.30
▸ EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21779826 0.93 ENPP3 (0.32) —
SCHEMBL24974327 0.90 NR1I2 (0.33) —
SCHEMBL25106939 0.86 ENPP3 (0.31) —
SCHEMBL20096318 0.77 ENPP3 (0.34) —
SCHEMBL26524246 0.77 ENPP3 (0.32) —
SCHEMBL21236452 0.69 ATP4A (0.33) —
SCHEMBL25898714 0.69 GPR84 (0.32) —
SCHEMBL30079608 0.69 — —
SCHEMBL14865768 0.68 DNM1 (0.36) —
SCHEMBL23838524 0.68 GPR88 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009433-B1 2-PHENYL-1,3-OXAZOLE AND 5-PHENYL-1,2,4-OXADIAZOLE DERIVATIVES FOR THE TREATMENT OF DIABETES DAIICHI SANKYO CO LTD (JP) 2017-06-21 — — EP disclosed
Send feedback